There are about 1 million birth defects in our country every year, with an incidence of 5.6%; the number of infertility patients exceeds 50 million, with an incidence of 12.5-15%; about 3.12 million tumors occur each year, with an incidence of 6.4%. With the development of high-throughput sequencing technology, it has brought good news to the prevention, diagnosis and treatment of genetic diseases and cancer. The government has also increased the support for this technology. Genetic consultation is essential for the transformation of genetic sequencing to clinical applications. The genetic counselors can not only promote advanced genetics knowledge and technology to the public in an easy-to-understand manner, but also provide patients with genetic counseling, diagnosis, therapy and other related medical services, which provides suggestions and related solutions for the public’s genetic problems The program enables the rapid and accurate transformation of advanced technologies into clinical applications.
As a leading company in the field of genetic reproduction, Yikon Genomics genetic consulting team adheres to the mission of "For the Health of Billions", using the mode of remote consultation to interpret reports, assess the risk of disease, and identify the cause of disease for free, as well as offering detection and preventive measures suggestion. A variety of high-efficiency and rapid detection and diagnosis methods for blocking single-gene genetic diseases and chromosomal genetic diseases invented by Yikon Genomics have also been widely used in genetic reproduction at home and abroad. At present, the genetic counseling team of Yikon has received more than 5,000 consultations, including genetic counseling and diagnosis of more than 100 genetic diseases, and has successfully helped more than 2,000 families get healthy babies. In the future, the genetic counseling team of Yikon will continue to take "For the Health of Billions " as mission to provide reliable genetic counseling services for genetic disease patients.